|
1
|
Wischke C and Schwendeman SP: Principles
of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int
J Pharm. 364:298–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang LY, Cai MM, Liu Y, Yang T, Zeng Y,
Zhang Y, Li Q, Zhu B and Ma G: Polymer hydrophobicity regulates
paclitaxel distribution in microspheres, release profile and
cytotoxicity in vitro. Powder Technology. 275:77–84. 2015.
View Article : Google Scholar
|
|
3
|
Zhao J, Wang L, Fan C, Yu K, Liu X, Zhao
X, Wang D, Liu W, Su Z, Sun F and Li Y: Development of near
zero-order release PLGA-based microspheres of a novel
antipsychotic. Int J Pharm. 516:32–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Amann LC, Gandal MJ, Lin R, Liang Y and
Siegel SJ: In vitro-in vivo correlations of scalable
PLGA-risperidone implants for the treatment of schizophrenia. Pharm
Res. 27:1730–1737. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
D'Souza S, Faraj J and DeLuca P:
Microsphere delivery of Risperidone as an alternative to
combination therapy. Eur J Pharm Biopharm. 85:631–639. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Okada H: One- and three-month release
injectable microspheres of the LH-RH superagonist leuprorelin
acetate. Adv Drug Deliv Rev. 28:43–70. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharifi R, Knoll LD, Smith J and
Kramolowsky E: Leuprolide acetate (30-mg depot every four months)
in the treatment of advanced prostate cancer. Urology. 51:271–276.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta SL, Rao KP, Choudary K and Pratima
S: Preformulation studies of biodegradable drug implants of
meloxicam for orthopedic patient care. J Pharm Sci Technol.
3:494–498. 2011.
|
|
9
|
Takada S, Kurokawda T, Miyazaki K, Iwasa S
and Ogawa Y: Utilization of an amorphous form of a water-soluble
GPIIb/IIIa antagonist for controlled release from biodegradable
microspheres. Pharm Res. 14:1146–1150. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Makino K, Mogi T, Ohtake N, Yoshida M,
Ando S, Nakajima T and Ohshima H: Pulsatile drug release from
poly(lactide-co-glycolide) microspheres: How does the composition
of the polymer matrices affect the time interval between the
initial burst and the pulsatile release of drugs? Colloids Surf B
Biointerfaces. 19:173–179. 2000. View Article : Google Scholar
|
|
11
|
Ghalanbor Z, Körber M and Bodmeier R:
Improved lysozyme stability and release properties of
poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.
Pharm Res. 27:371–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun F, Sui C, Teng L, Liu X, Teng L, Meng
Q and Li Y: Studies on the preparation, characterization and
pharmacological evaluation of tolterodine PLGA microspheres. Int J
Pharm. 397:44–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kazuhiko J, Masahiro N and Miho K:
Controlled release of aclarubicim, an anticancer antibiotic, from
poly-β-hydroxybutyric acid microspheres. J Controlled Release.
4:25–32. 1986. View Article : Google Scholar
|
|
14
|
Munarin F, Giuliano L, Bozzini S, Tanzi MC
and Petrini P: Mineral phase deposition on pectin microspheres. Mat
Sci Eng C. 30:491–496. 2010. View Article : Google Scholar
|
|
15
|
Ni L, Jie X, Wang P, Li S, Hu S, Li Y, Li
Y and Acharya K: Characterization of unsaturated fatty acid
sustained-release microspheres for long-term algal inhibition.
Chemosphere. 120:383–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Angadi SC, Manjeshwar LS and Aminabhavi
TM: Stearic acid-coated chitosan-based interpenetrating polymer
network microspheres: Controlled release characteristics. Ind Eng
Chem Res. 50:4504–4514. 2011. View Article : Google Scholar
|
|
17
|
Urata T, Arimori K and Nakano M:
Modification of release rates of cyclosporin A from polyl(L-lactic
acid) microspheres by fatty acid esters and in-vivo evaluation of
the microspheres. J Control Release. 58:133–141. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chwieduk CM and Keating GM: Paliperidone
extended release: A review of its use in the management of
schizophrenia. Drugs. 70:1295–1317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun F, Su Z, Sui C, Zhang C, Yuan L, Meng
Q, Teng L and Li Y: Studies on the acute toxicity, pharmacokinetics
and pharmacodynamics of paliperidone derivatives-comparison to
paliperidone and risperidone in mice and rats. Basic Clin Pharmacol
Toxicol. 107:656–662. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarı A, Biçer A and Karaipekli A:
Synthesis, characterization, thermal properties of a series of
stearic acid esters as novel solid-liquid phase change materials.
Mat Lett. 63:1213–1216. 2009. View Article : Google Scholar
|
|
21
|
Huang W, Shi YN, Wang CH, Yu KT, Sun FY
and Li YX: Using spray-dried lactose monohydrate in wet granulation
method for a low-dose oral formulation of a paliperidone
derivative. Powder Technol. 246:379–394. 2013. View Article : Google Scholar
|
|
22
|
Lu S, Xing J, Zhang Z and Jia G:
Preparation and characterization of polyurea/polyurethane
double-shell microcapsules containing butyl stearate through
interfacial polymerization. J Appl Poly Sci. 121:3377–3383. 2011.
View Article : Google Scholar
|
|
23
|
Sakamoto S, Komatsu T, Ueno T, Hanaoka K
and Urano Y: Fluorescence detection of serum albumin with a
turnover-based sensor utilizing Kemp elimination reaction. Bioorg
Med Chem Lett. 27:3464–3467. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vrancken MN and Claeys DA: Process for
encapsulating water and compounds in aqueous phase by evaporation.
US Patent 3,523,906. Filed April 25, 1968; issued. August
11–1970.
|
|
25
|
Wang J and Schwendeman SP: Mechanisms of
solvent evaporation encapsulation processes: Prediction of solvent
evaporation rate. J Pharm Sci. 88:1090–1099. 1999.PubMed/NCBI
|
|
26
|
Birnbaum DT, Kosmala JD, Henthorn DB and
Brannon-Peppas L: Controlled release of beta-estradiol from PLAGA
microparticles: The effect of organic phase solvent on
encapsulation and release. J Control Release. 65:375–387. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soppimath KS and Aminabhavi TM: Ethyl
acetate as a dispersing solvent in the production of
poly(DL-lactide-co-glycolide) microspheres: Effect of process
parameters and polymer type. J Microencapsul. 19:281–292. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Birnbaum DT and Brannon-Peppas L:
Microparticle drug delivery systems. Drug Delivery Systems in
Cancer Therapy (Springer). 117–135. 2004.
|
|
29
|
Mogi T, Ohtake N, Yoshida M, Chimura R,
Kamaga Y, Ando S, Tsukamoto T, Nakajima T, Uenodan H, Otsuka M, et
al: Sustained release of 17β-estradiol from
poly(lactide-co-glycolide) microspheres in vitro and in vivo.
Colloids Surface B Biointerfaces. 17:153–165. 2000. View Article : Google Scholar
|
|
30
|
Mao SR, Shi Y, Li L, Xu J, Schaper A and
Kissel T: Effects of process and formulation parameters on
characteristics and internal morphology of
poly(D,L-lactide-co-glycolide) microspheres formed by the solvent
evaporation method. Eur J Pharm Biopharm. 68:214–223. 2008.
View Article : Google Scholar : PubMed/NCBI
|
